Literature DB >> 3553112

Skeletal metastases from cancer of the uterine cervix: frequency, patterns, and radiotherapeutic significance.

R Y Kim, B Weppelmann, M M Salter, D J Brascho.   

Abstract

The records of eight hundred two patients who received primary radiotherapy for invasive cervical cancer between 1969 and 1985 were reviewed. The incidence of bone metastasis was 1.9% (15/802). Lumbar spine involvement was the most common site, followed by the pelvic bones. Lumbar spine involvement was characterized by unilateral destruction of one or several contiguous vertebrae. All 10 patients with lumbar spine involvement were associated with a para-spinal mass. In seven of ten patients, this bone destruction due to direct extension from metastatic para-aortic tumor was the only recurrent cancer. In contrast, involvement of a long bone, a rib or the skull indicates hematogenous bone metastasis. When a spine X ray or bone scan is positive in the lumbar area in a cervical cancer patient with back pain, a CT scan should be performed to determine the extent of the underlying tumor. This will allow more accurate establishment of a radiation treatment plan, and will improve the chances for successful palliation.

Entities:  

Mesh:

Year:  1987        PMID: 3553112     DOI: 10.1016/0360-3016(87)90288-4

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

1.  Interdisciplinary clinical evaluation of 58 patients with lumbar-vertebral metastases from cervico-uterine cancer.

Authors:  Víctor Valdespino Gómez; Juan M Salgado Cazares; Gaspar González Astudillo; Víctor E Valdespino Castillo
Journal:  Clin Transl Oncol       Date:  2005-11       Impact factor: 3.405

2.  Indications for radioisotope bone scanning in staging of cervical cancer.

Authors:  P Hirnle; K P Mittmann; B Schmidt; K H Pfeiffer
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

Review 3.  Imaging and cancer of the cervix in low- and middle-income countries.

Authors:  J Olpin; L Chuang; J Berek; D Gaffney
Journal:  Gynecol Oncol Rep       Date:  2018-07-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.